Skip to main content
SpringerLink
Log in
Book cover

Antibody Therapy pp 213–222Cite as

Health-Related Quality of Life in Patients with Immune Thrombocytopenia

  • Chapter
  • First Online:

  • 1172 Accesses

Abstract

I walked into the examination room to see my second patient of the day—five other families were quietly sitting in the waiting room awaiting their turn. She was a 15-year-old girl with immune thrombocytopenia (ITP) diagnosed just over 1 year ago. Her platelet count ranged from 20 to 30 × 109/l, but she had not required any emergency department visits or had any significant bleeding events over the past 6 months. All in all she seemed stable, so my plan was to continue with the current treatment approach of “watch and wait”.

This is a preview of subscription content, log in via an institution.

References

  • Barnard D, Woloski M, Feeny D, McCusker P, Wu J, David M, Bussel J, Lusher J, Wakefield C, Henriques S, Blanchette V. Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents. J Pediatr Hematol Oncol. 2003;25(1):56–62.

    Article  PubMed  Google Scholar 

  • Bussel JB, Cheng G, Saleh MN, Psaila B, Kovaleva L, Meddeb B, Kloczko J, Hassani H, Mayer B, Stone NL, Arning M, Provan D, Jenkins JM. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med. 2007;357(22):2237–47.

    Article  CAS  PubMed  Google Scholar 

  • Bussel JB, de Miguel PG, Despotovic JM, Grainger JD, Sevilla J, Blanchette VS, Krishnamurti L, Connor P, David M, Boayue KB, Matthews DC, Lambert MP, Marcello LM, Iyengar M, Chan GW, Chagin KD, Theodore D, Bailey CK, Bakshi KK. Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study. Lancet Haematol. 2015;2(8):e315–25.

    Article  PubMed  Google Scholar 

  • Calman KC. Quality of life in cancer patients—an hypothesis. J Med Ethics. 1984;10(3):124–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Efficace F, Mandelli F, Fazi P, Santoro C, Gaidano G, Cottone F, Borchiellini A, Carpenedo M, Simula MP, Di Giacomo V, Bergamaschi M, Vincelli ID, Rodeghiero F, Ruggeri M, Scaramucci L, Rambaldi A, Cascavilla N, Forghieri F, Petrungaro A, Ditonno P, Caocci G, Cirrincione S, Mazzucconi MG. Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease. Am J Hematol. 2016;91(10):995–1001.

    Article  PubMed  Google Scholar 

  • Eiser C, Jenney M. Measuring quality of life. Arch Dis Child. 2007;92(4):348–50.

    Article  PubMed  PubMed Central  Google Scholar 

  • Flores A, Klaassen RJ, Buchanan GR, Neunert CE. Patterns and influences in health-related quality of life in children with immune thrombocytopenia: a study from the Dallas ITP Cohort. Pediatr Blood Cancer. 2017;64(8):e26405.

    Article  Google Scholar 

  • George JN, Mathias SD, Go RS, Guo M, Henry DH, Lyons R, Redner RL, Rice L, Schipperus MR. Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials. Br J Haematol. 2009;144(3):409–15.

    Article  CAS  PubMed  Google Scholar 

  • Grace R, Despotovic J, Bennett C, Klaassen RJ. Fatigue in pediatric immune thrombocytopenia (ITP): baseline prevalence in patients starting second line therapies in the first ITP consortium of North America research study (ICON1). Pediatr Blood Cancer. 2016;63(S1):S20. Ref Type: Abstract.

    Google Scholar 

  • Grainger JD, Young NL, Blanchette VS, Klaassen RJ. Quality of life in immune thrombocytopenia following treatment. Arch Dis Child. 2013;98(11):895–7.

    Article  PubMed  Google Scholar 

  • Greenhalgh J. The applications of PROs in clinical practice: what are they, do they work, and why? Qual Life Res. 2009;18(1):115–23.

    Article  PubMed  Google Scholar 

  • Heitink-Polle KM, Haverman L, Annink KV, Schep SJ, de HM, Bruin MC. Health-related quality of life in children with newly diagnosed immune thrombocytopenia. Haematologica. 2014;99(9):1525–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hill QA, Newland AC. Fatigue in immune thrombocytopenia. Br J Haematol. 2015;170(2):141–9.

    Article  PubMed  Google Scholar 

  • Klaassen RJ, Blanchette V, Burke TA, Wakefield C, Grainger JD, Gaedicke G, Riedlinger A, Dufort G, Citrin E, Reguerre Y, Pellier I, Curtis C, Young NL. Quality of life in childhood immune thrombocytopenia: international validation of the kids’ ITP tools. Pediatr Blood Cancer. 2013;60(1):95–100.

    Article  PubMed  Google Scholar 

  • Klaassen RJ, Blanchette VS, Barnard D, Wakefield CD, Curtis C, Bradley CS, Neufeld EJ, Buchanan GR, Silva MP, Chan AK, Young NL. Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the kids’ ITP tools. J Pediatr. 2007;150(5):510–5.

    Article  PubMed  Google Scholar 

  • Klaassen RJ, Mathias SD, Buchanan G, Bussel J, Deuson R, Young NL, Collier A, Bomgaars L, Blanchette V. Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP). Pediatr Blood Cancer. 2011;58(3):395–8.

    Article  PubMed  Google Scholar 

  • Klaassen RJ, Young NL. Health-related quality of life outcomes for patients with immune thrombocytopenic purpura. Ann Hematol. 2010;89(1):51–4.

    Article  PubMed  Google Scholar 

  • Kuter DJ, Rummel M, Boccia R, Macik BG, Pabinger I, Selleslag D, Rodeghiero F, Chong BH, Wang X, Berger DP. Romiplostim or standard of care in patients with immune thrombocytopenia. N Engl J Med. 2010;363(20):1889–99.

    Article  CAS  PubMed  Google Scholar 

  • Mathias SD, Bussel JB, George JN, McMillan R, Okano GJ, Nichol JL. A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation. Health Qual Life Outcomes. 2007;5:11.

    Article  PubMed  PubMed Central  Google Scholar 

  • Mathias SD, Gao SK, Rutstein M, Snyder CF, Wu AW, Cella D. Evaluating clinically meaningful change on the ITP-PAQ: preliminary estimates of minimal important differences. Curr Med Res Opin. 2009;25(2):375–83.

    Article  PubMed  Google Scholar 

  • McMillan R, Bussel JB, George JN, Lalla D, Nichol JL. Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol. 2008;83(2):150–4.

    Article  PubMed  Google Scholar 

  • Mokhtar GM, Farid SM, Shaker NM, Farrag KE. Health-related quality of life of Egyptian children with immune thrombocytopenia and their parents. J Pediatr Hematol Oncol. 2014;36(3):194–9.

    Article  PubMed  Google Scholar 

  • Neunert CE, Buchanan GR, Blanchette V, Barnard D, Young NL, Curtis C, Klaassen RJ. Relationships among bleeding severity, health-related quality of life, and platelet count in children with immune thrombocytopenic purpura. Pediatr Blood Cancer. 2009;53(4):652–4.

    Article  PubMed  Google Scholar 

  • Newton JL, Reese JA, Watson SI, Vesely SK, Bolton-Maggs PH, George JN, Terrell DR. Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol. 2011;86(5):420–9.

    Article  PubMed  Google Scholar 

  • Sanz MA, Aledort L, Mathias SD, Wang X, Isitt JJ. Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP). Value Health. 2011;14(1):90–6.

    Article  PubMed  Google Scholar 

  • Snyder CF, Mathias SD, Cella D, Isitt JJ, Wu AW, Young J. Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey. Curr Med ResOpin. 2008;24(10):2767–76.

    Article  Google Scholar 

  • Tarantino MD, Bussel JB, Blanchette VS, Despotovic J, Bennett C, Raj A, Williams B, Beam D, Morales J, Rose MJ, Carpenter N, Nie K, Eisen M. Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study. Lancet. 2016;388(10039):45–54.

    Article  PubMed  Google Scholar 

  • Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. 2003;3(6):329–41.

    Article  PubMed  Google Scholar 

  • Ware JE. SF-36 health survey update. In: Maruish ME, editor. The use of psychological testing for treatment planning and outcome assessment, vol. 3. 3rd ed. Mahwah: Lawrence Erlbaum Associates; 2004. p. 693–718.

    Google Scholar 

  • WHOQOL Group. Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Qual Life Res. 1993;2(2):153–9.

    Article  Google Scholar 

  • Zhou Z, Yang L, Chen Z, Chen X, Guo Y, Wang X, Dong X, Wang T, Zhang L, Qiu Z, Yang R. Health-related quality of life measured by the Short Form 36 in immune thrombocytopenic purpura: a cross-sectional survey in China. Eur J Haematol. 2007;78(6):518–23.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Department of Pediatrics, University of Ottawa, Children’s Hospital of Eastern Ontario, 401 Smyth, Ottawa, ON, Canada, K1H 8L1

    Robert J. Klaassen MD

  2. School of Rural and Northern Health, Laurentian University, Sudbury, ON, Canada

    Nancy L. Young PhD

Authors
  1. Robert J. Klaassen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nancy L. Young PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert J. Klaassen MD .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, Medical Faculty of the University of Basel, Basel, Switzerland

    Paul Imbach

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Klaassen, R.J., Young, N.L. (2018). Health-Related Quality of Life in Patients with Immune Thrombocytopenia. In: Imbach, P. (eds) Antibody Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-68038-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-68038-5_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-68037-8

  • Online ISBN: 978-3-319-68038-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation